Skip to main content

Table 1 Patients’ characteristics

From: Linking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133+ cells in ischemic refractory cardiomyopathy trial (RECARDIO)

Characteristic Baseline
Age (years), mean ± SD 69.4 ± 3.8
Males, n/total 10/10
BMI (kg/m2), mean ± SD 26.3 ± 2.4
Cardiovascular risk factors, n/total
 Current smoking 7/10
 Diabetes mellitus 6/10
 Hypertension 10/10
 Hypercholesterolemia 9/10
 Family history of CAD 6/10
Medical history, n/total
 Prior CABG 10/10
 Prior MI 7/10
 Prior PCI 8/10
 Prior ICD implant 2/10
 Spinal cord stimulation 2/10
 Peripheral vascular disease 1/10
Current medications, n/total
 β-Blockers 9/10
 ACE inhibitors 5/10
 ARBs 3/10
 Calcium antagonists 1/10
 Diuretics 6/10
 Statins 10/10
 Aspirin 8/10
 Ranolazine 7/10
 Long-lasting nitroglycerin 6/10
Cardiovascular condition at enrolment, mean ± SD
 LVEF (%) 38.3 ± 5.1
 LV reversible ischemia (%) 15.3 ± 8.4
 Peak VO2 (ml/kg/min) 13.3 ± 1.8
  1. Continuous data presented as mean ± SD
  2. SD standard deviation, BMI body mass index, CAD coronary artery disease, CABG coronary artery bypass grafting, MI myocardial infarction, PCI percutaneous coronary intervention, ICD implantable cardioverter defibrillator, ACE angiotensin converting enzyme, ARB angiotensin II receptor blocker, LVEF left ventricular ejection fraction, LV left ventricle, VO2 oxygen consumption